Hartung, H.-P. and Freedman, M. S. and Polman, C. H. and Edan, G. and Kappos, L. and Miller, D. H. and Montalbán, X. and Barkhof, F. and Petkau, J. and White, R. and Sahajpal, V. and Knappertz, V. and Beckmann, K. and Lanius, V. and Sandbrink, R. and Pohl, C. and Benefit Study Group, . (2011) Interferon β-1b-neutralizing antibodies 5 years after clinically isolated syndrome. Neurology, Vol. 77, H. 9. pp. 835-843.
Full text not available from this repository.
Official URL: http://edoc.unibas.ch/dok/A6004556
Downloads: Statistics Overview
Abstract
To determine the frequency and consequences of neutralizing antibodies (NAbs) in patients with a first event suggestive of multiple sclerosis (MS) treated with interferon ?-1b (IFN?-1b).
| Faculties and Departments: | 03 Faculty of Medicine > Bereich Medizinische Fächer (Klinik) > Neurologie > Neuroimmunologie (Kappos) 03 Faculty of Medicine > Departement Klinische Forschung > Bereich Medizinische Fächer (Klinik) > Neurologie > Neuroimmunologie (Kappos) |
|---|---|
| UniBasel Contributors: | Kappos, Ludwig |
| Item Type: | Article, refereed |
| Article Subtype: | Research Article |
| Publisher: | Lancet Publications |
| ISSN: | 0028-3878 |
| Note: | Publication type according to Uni Basel Research Database: Journal article |
| Identification Number: | |
| Last Modified: | 06 Dec 2013 09:36 |
| Deposited On: | 06 Dec 2013 09:36 |
Repository Staff Only: item control page